TY - JOUR
T1 - Contribution of telemedicine and information technology to hypertension control
AU - Pellegrini, Dario
AU - Torlasco, Camilla
AU - Ochoa, Juan Eugenio
AU - Parati, Gianfranco
N1 - Publisher Copyright:
© 2020, The Japanese Society of Hypertension.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Due to fast-paced technological advancements, digital health and telemedicine represent a promising and complex reality, with the potential to change the current management of hypertension and improve its outcomes. New types of health-related strategies are available, ranging from telemonitoring of blood pressure (BP) values to counseling for patients and decisional tools for physicians, thanks to the development of new technology. Even though the strength of available evidence is currently low due to the high heterogeneity of studies and of the proposed interventions, available data suggest a beneficial effect of digital health strategies on BP control and, more generally, on cardiovascular risk reduction. In addition, well-designed randomized controlled trials are needed to further investigate the real impact of these new strategies on clinical outcomes. Furthermore, due to consistent commercial interests in this field, there is a strong need for strict regulations to ensure a safe and secure implementation of this new reality in clinical care.
AB - Due to fast-paced technological advancements, digital health and telemedicine represent a promising and complex reality, with the potential to change the current management of hypertension and improve its outcomes. New types of health-related strategies are available, ranging from telemonitoring of blood pressure (BP) values to counseling for patients and decisional tools for physicians, thanks to the development of new technology. Even though the strength of available evidence is currently low due to the high heterogeneity of studies and of the proposed interventions, available data suggest a beneficial effect of digital health strategies on BP control and, more generally, on cardiovascular risk reduction. In addition, well-designed randomized controlled trials are needed to further investigate the real impact of these new strategies on clinical outcomes. Furthermore, due to consistent commercial interests in this field, there is a strong need for strict regulations to ensure a safe and secure implementation of this new reality in clinical care.
KW - Arterial hypertension
KW - Digital health
KW - Home blood pressure
KW - mHealth
KW - Telemonitoring
UR - http://www.scopus.com/inward/record.url?scp=85082822952&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082822952&partnerID=8YFLogxK
U2 - 10.1038/s41440-020-0422-4
DO - 10.1038/s41440-020-0422-4
M3 - Review article
C2 - 32203451
AN - SCOPUS:85082822952
VL - 43
SP - 621
EP - 628
JO - Hypertension Research
JF - Hypertension Research
SN - 0916-9636
IS - 7
ER -